Oral Cancer Clinical Trial
Official title:
Randomized Controlled Trial of IIb Preserving Neck Dissection VS Neck Dissections Involving IIb Removal (Selective/Functional) in Patients With N0 Neck With Oral Cavity Malignancies
The treatment of clinically N0 neck in malignancies of oral cavity is controversial. The
options include the policy of "wait and watch"(close observation and follow-up), elective
irradiation of the neck, elective surgery of the neck (neck dissection).
In elective neck dissections, the procedures commonly performed are modified radical neck
dissection-III (functional neck dissection) and selective (supraomohyoid) neck dissection
depending on the site of the primary lesion within the oral cavity. There are no trials of
IIb preserving neck dissection in cancers of the oral cavity.
Surgery of the cervical lymphatic system has evolved a lot since the introduction of
classical radical neck dissection by Crile in 1906, which was later established by Martin
(1945). It includes the removal of cervical lymphatic levels I-V along with removal of
non-lymphatic structures namely submandibular gland, tail of parotid, omohyoid muscle,
cervical plexus of nerves, spinal accessory nerve, internal jugular vein and
sternocleidomastoid muscle. The main morbidity of the radical neck dissection was the
trapezius muscle dysfunction with shoulder drop, resulting in pain and shoulder dysfunction.
The other morbidities of radical neck dissection were cosmetic deformity of neck, painful
neuromas, increased facial swelling, numbness of neck and ear.
In the last three decades, many modifications of the classical radical neck dissection
(modified radical neck dissections), had been described and are increasingly applied. The
main modifications have been the preservation of one or more of the non-lymphatic structures
that were removed in classical radical neck dissection mainly the spinal accessory nerve,
internal jugular vein, sternocleidomastoid muscle (Bocca and Pignataro, 1967). The reasons
for developing these modifications were functional and cosmetic, while preserving the
oncological safety of the procedure.
Much later in 1980s, the concept of selective neck dissection, for which Lindberg (1972) and
Skolnik (1976) laid down important basis, was introduced. In selective neck dissections only
those groups of lymph nodes are removed, which, depending upon the location of the primary
tumour, are most likely to contain metastasis (Shah, 1990).
The first selective neck dissection introduced was the supraomohyoid neck dissection, which
includes the removal of lymph node levels I-III, while preserving the non-lymphatic
structures as functional neck dissection. Medina and Byers in a prospective study have
demonstrated the utility of this supraomohyoid neck dissection in patients with clinically
negative neck nodes (N0) with malignancies of oral cavity.
The posterolateral neck dissection removes lymph node levels II-V as well as retroauricular
and suboccipital nodes, which is used primarily for treatment of tumours of scalp and post
auricular skin.
The lateral neck dissection, which includes removal of lymph node levels II-IV, is done for
tumours of larynx or hypopharynx with N0 neck.
The anterior compartment neck dissection includes removal of only lymph node level VI which
is done in thyroid malignancies when there is no evidence of lateral lymphadenopathy, and is
combined with lateral neck dissection(anterolateral) if there are lymphnodes involved.
Recently the concept of superselective neck dissections has been introduced. It is less
radical than selective neck dissections, removing lesser number of at-risk lymph nodal
groups.
H Coskun (2004) found IIb preserving superselective neck dissection as oncologically safe
procedure in N0 laryngeal cancer, with more functional preservation of trapezius muscle and
hence negligible shoulder disability. In this study, it was found that even in selective neck
dissection, some degree of spinal accessory nerve dysfunction and shoulder disability occurs
as a result of retraction of the nerve during the clearance of the lymph nodes posterior and
superior to the nerve (IIb). If these lymph nodes were not removed and left in place, there
would be no stretching of spinal accessory nerve during the neck dissection and shoulder
disability could be avoided
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06031337 -
Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
|
||
Completed |
NCT00158678 -
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
|
Phase 3 | |
Completed |
NCT00933387 -
A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma
|
Phase 2 | |
Enrolling by invitation |
NCT05030597 -
Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma
|
N/A | |
Completed |
NCT03682562 -
Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
|
||
Recruiting |
NCT03684707 -
Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions
|
Phase 4 | |
Recruiting |
NCT06130332 -
Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)
|
Phase 2 | |
Recruiting |
NCT04372914 -
Prevention of Oral DNA Damage by Black Raspberries
|
N/A | |
Active, not recruiting |
NCT03529422 -
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
|
Phase 2 | |
Recruiting |
NCT03686020 -
Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)
|
||
Not yet recruiting |
NCT06060288 -
Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening
|
||
Withdrawn |
NCT00951470 -
Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema
|
N/A | |
Completed |
NCT00964977 -
Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
|
Phase 3 | |
Completed |
NCT01418118 -
Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery
|
Phase 4 | |
Active, not recruiting |
NCT00232960 -
Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
|
N/A | |
Recruiting |
NCT05429099 -
Mandibular Reconstruction Preplanning (ViPMR)
|
Phase 2/Phase 3 | |
Completed |
NCT04614896 -
Use of Ultrasound for Measuring Size of Oral Tongue Cancers
|
N/A | |
Recruiting |
NCT03685409 -
Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions
|
Phase 3 | |
Completed |
NCT00402779 -
Erlotinib Prevention of Oral Cancer (EPOC)
|
Phase 3 | |
Recruiting |
NCT05153733 -
Improved Implant for Reconstruction Purposes After Mandibular Resection
|
N/A |